Biotechnology Telemedicine Law In Russia.

1. Introduction

Biotechnology Telemedicine Law in Russia concerns the legal regulation of healthcare services delivered through digital communication technologies, biotechnology-based diagnostic systems, remote patient monitoring, genetic testing, artificial intelligence (AI), electronic medical records and connected medical devices.

Telemedicine is particularly important in biotechnology because modern medical treatment increasingly relies on biological information collected remotely, including:

Genetic and genomic test results.

Molecular diagnostic reports.

Biomarker information.

Blood and laboratory test results.

Digital pathology and medical imaging.

Remote monitoring of biological functions.

AI-assisted diagnosis and treatment recommendations.

Personalised medicine and pharmacogenomic information.

Russian law does not establish one comprehensive statute specifically called the Biotechnology Telemedicine Act. Instead, telemedicine and biotechnology are regulated through several interconnected federal laws, government regulations and Ministry of Health orders.

The principal legal framework is Federal Law No. 323-FZ of 21 November 2011, On the Fundamentals of Health Protection of Citizens in the Russian Federation, particularly Article 36.2.

An important recent development is Ministry of Health Order No. 193n of 11 April 2025, which introduced an updated procedure for organising and providing medical assistance using telemedicine technologies from 1 September 2025.

Consultant Plus+2

 

2. Constitutional foundation of biotechnology telemedicine

The Russian Constitution provides the foundation for regulating digital healthcare and biotechnology-based medical services.

Important constitutional provisions include:

Article 41 – Right to health protection and medical assistance

This article recognises the right of citizens to health protection and medical assistance. It provides the constitutional basis for developing accessible medical services, including lawful remote consultations.

Article 21 – Human dignity

Biotechnology-based medical services must respect human dignity, bodily integrity and the individual's interests.

Article 23 – Privacy

Patients' private medical information, genetic information and personal communications require legal protection.

Article 24 – Protection of personal information

The collection, storage and use of information concerning individuals must comply with applicable legal requirements.

Article 46 – Judicial protection

Patients may seek judicial protection when medical organisations violate their rights through unlawful treatment, disclosure of confidential information or negligent remote medical services.

These provisions must be read together with federal healthcare, personal-data and medical-secrecy legislation.

3. Principal legislation governing telemedicine

A. Federal Law No. 323-FZ of 2011

This is the principal legislation governing medical activity in Russia.

Article 36.2 regulates medical assistance provided using telemedicine technologies.

Its principal objectives include:

Prevention and early identification of health problems.

Collection and analysis of patient complaints and medical history.

Assessment of treatment effectiveness.

Remote medical observation.

Determining whether a patient requires an in-person examination.

Supporting communication between medical professionals.

A particularly important limitation is that remote consultations generally cannot replace the initial in-person diagnosis and treatment process.

Under Article 36.2(3), a treating doctor may adjust previously prescribed treatment during a telemedicine consultation where the doctor has established the diagnosis and prescribed the treatment during an in-person appointment.

Article 36.2 also requires compliance with personal-data legislation and medical secrecy.

Consultant Plus+1

 

B. Ministry of Health Order No. 193n of 2025

Effective 1 September 2025

Order No. 193n is particularly important because it replaced the earlier Order No. 965n of 2017.

It regulates the organisation and delivery of medical assistance using telemedicine technologies.

Its framework recognises:

Real-time consultations.

Deferred or asynchronous consultations.

Remote consultations between medical professionals.

Medical consultations involving patients.

Remote monitoring of patient health.

Use of registered AI-based clinical decision-support systems in relevant deferred consultations.

The Order also addresses emergency, urgent and planned medical assistance.

This is significant for biotechnology because a specialist can assess laboratory information, medical imaging and remote-monitoring data without necessarily requiring simultaneous physical interaction with the patient.

ГАРАНТ+2

 

4. Licensing and registration of telemedicine providers

Telemedicine is not an unregulated internet service. Where an organisation provides medical assistance, it must comply with Russian medical licensing legislation.

The principal legislation includes:

Federal Law No. 99-FZ of 4 May 2011 – Licensing of Certain Types of Activities.

Federal Law No. 323-FZ of 2011 – medical activity and patient protection.

Government licensing regulations governing medical activities.

Ministry of Health Order No. 193n of 2025 – telemedicine procedures.

A medical organisation must ensure that its medical activity is appropriately licensed and that professionals providing consultations have the necessary qualifications.

Biotechnology companies

A biotechnology company developing telemedicine products must distinguish between:

Providing medical services.

Supplying diagnostic software.

Manufacturing medical devices.

Providing laboratory testing.

Offering genetic-analysis services.

Developing AI-based diagnostic platforms.

These activities may attract different licensing, registration and regulatory requirements.

For example, a company selling a software platform to hospitals does not automatically become a medical provider. However, software performing a regulated medical-device function may require registration under Article 38 of Federal Law No. 323-FZ.

5. Regulation of biotechnology-based medical devices

Article 38 of Federal Law No. 323-FZ regulates medical devices.

This is especially important for telemedicine platforms using biotechnology and digital diagnostic equipment.

Examples include:

Portable DNA-testing equipment.

Remote blood-analysis devices.

Digital pathology systems.

Biosensors.

Continuous glucose-monitoring devices.

Molecular diagnostic instruments.

AI-based diagnostic software.

Remote cardiac and neurological monitoring equipment.

Medical devices generally require state registration before being placed into ordinary medical circulation in Russia, subject to applicable statutory exceptions and special regulatory arrangements.

The regulatory objective is to ensure that medical devices satisfy relevant safety, quality and performance requirements.

Legal significance: A telemedicine platform cannot avoid medical-device regulation merely by describing its diagnostic technology as ordinary software.

6. Genetic data and genomic information in telemedicine

Genetic information creates special legal difficulties because it can reveal information about an individual's biological characteristics and potentially about relatives.

Russian legislation does not create a single comprehensive legal regime specifically for every category of genomic information used in telemedicine.

However, several laws apply.

A. Federal Law No. 152-FZ of 27 July 2006 – Personal Data

Health-related information is generally subject to enhanced personal-data protection.

Under this legislation, information concerning health falls within the category of special personal data.

The processing of such information must satisfy the applicable statutory grounds, consent requirements and security obligations.

B. Federal Law No. 323-FZ – Medical Secrecy

Article 13 protects information concerning:

Medical consultations.

Diagnosis.

Patient health.

Medical examinations.

Treatment.

Other information obtained during medical care.

Medical secrecy applies to telemedicine just as it applies to traditional medical treatment.

C. Genetic testing and biotechnology research

Where telemedicine involves genetic testing or genomic research, additional requirements may arise under legislation governing genetic research, medical examinations, biomedical research and informed consent.

For example, a telemedicine provider should not assume that consent to an online consultation automatically authorises the commercial reuse of a patient's genomic information.

minzdrav.gov.ru+2

7. Electronic medical records and patient identification

Electronic documentation is an essential part of Russian telemedicine regulation.

Article 36.2 of Federal Law No. 323-FZ establishes requirements for identifying and authenticating participants in remote medical interactions.

It also requires medical documentation of telemedicine assistance to be authenticated using the medical professional's enhanced qualified electronic signature.

Important compliance areas include:

Patient identity verification.

Medical professional authentication.

Protection of electronic medical records.

Secure transmission of laboratory reports.

Preservation of consultation records.

Prevention of unauthorised access.

Proper documentation of medical decisions.

The use of the Unified System of Identification and Authentication (ESIA) is particularly relevant under the ordinary statutory framework, subject to applicable experimental-regime exceptions.

Consultant Plus+1

 

8. AI-based biotechnology telemedicine

Artificial intelligence is increasingly important in Russian digital healthcare.

Examples include:

AI-based cancer detection.

Automated genomic interpretation.

Digital pathology.

AI-assisted radiology.

Predictive disease modelling.

Personalised treatment recommendations.

AI-based analysis of molecular biomarkers.

Russian law does not treat every AI healthcare application as a medical device. Its classification depends on the intended purpose and functionality.

Where software qualifies as a medical device, Article 38 of Federal Law No. 323-FZ becomes relevant.

Order No. 193n of 2025 expressly recognises the use of qualifying AI-based clinical decision-support systems in deferred telemedicine consultations.

This does not mean that AI replaces the legally responsible medical professional.

Important legal principle: AI may support clinical decisions, but medical organisations and healthcare professionals must still comply with applicable medical standards, documentation obligations and patient-protection requirements.

ГАРАНТ+2

 

9. Pharmaceutical prescriptions and remote biotechnology treatment

Telemedicine may involve treatment recommendations concerning:

Biopharmaceutical products.

Vaccines.

Biological medicines.

Gene therapies.

Personalised medicines.

Specialised nutritional products.

Medicines selected using pharmacogenomic testing.

The principal legislation includes Federal Law No. 61-FZ of 12 April 2010, On the Circulation of Medicines.

However, telemedicine does not automatically authorise unrestricted remote prescribing.

The doctor must comply with applicable requirements concerning diagnosis, prescriptions, controlled medicines and the patient's clinical circumstances.

In particular, restrictions on prescribing certain controlled or specially regulated medicines cannot be avoided by using messaging applications or video consultations.

10. Cross-border biotechnology telemedicine

Cross-border telemedicine creates additional legal questions.

Consider a Russian patient receiving an online consultation from a foreign biotechnology specialist who analyses genomic information stored on a foreign server.

This situation can involve several legal issues:

Jurisdiction: Which country's medical regulations apply to the provider and the service?

Licensing: Does the foreign medical professional require Russian authorisation to provide medical assistance in Russia?

Data protection: Can the patient's medical and genetic information lawfully be transferred abroad?

Medical liability: Which country's law governs a medical negligence claim?

Medical devices: Does the diagnostic software or equipment require Russian registration?

Research consent: Can the genomic information be used for additional research?

Russian Federal Law No. 152-FZ and the applicable data-localisation requirements under Article 18(5) are particularly important when personal data is collected through Russian internet services.

The precise requirements depend on the identity of the data operator, the nature of processing and the transfer arrangement.

11. Judicial decisions and case laws

Russian telemedicine jurisprudence is developing. There is not yet a comprehensive body of Supreme Court precedent dealing exclusively with biotechnology-based telemedicine.

Nevertheless, several judicial decisions provide important guidance.

Case 1. Ninth Court of Cassation of General Jurisdiction, 6 February 2025

Direct telemedicine case

Case No. 8G-12682/2024 [88-819/2025-(88-12407/2024)]

This case concerned a child receiving medical treatment and the legality of a remote consultation between medical professionals.

The child's mother requested a telemedicine consultation with her participation. However, on 5 October 2023, a consultation was conducted in the format of doctor-to-doctor communication.

The mother challenged the consultation and questioned the accuracy of the medical documentation. She also sought compensation for moral harm.

The courts examined:

Whether doctor-to-doctor consultation was legally permissible.

Whether the patient's parent had to participate.

Whether the consultation was properly documented.

Whether the medical recommendations were consistent with existing medical records.

Whether the consultation violated the child's rights.

Judicial outcome: The Ninth Cassation Court upheld the lower courts' conclusions rejecting the claims.

The court accepted that a doctor-to-doctor telemedicine consultation could lawfully be conducted on the treating doctor's initiative in the circumstances of the case. The child's parent's participation was not legally indispensable for that particular consultation.

Legal principle: Telemedicine can lawfully facilitate professional medical consultations without direct patient participation in every instance, provided the applicable procedure and clinical circumstances justify that format.

This case is particularly relevant to remote biotechnology consultations where specialists interpret laboratory or genomic information supplied by another treating professional.

ГАРАНТ

 

Case 2. Eighth Court of Cassation, 31 October 2024

Case No. 8G-20782/2024 [88-21563/2024]

This case concerned the technical and legal requirements for concluding contracts for paid medical services remotely.

The dispute involved the availability of the necessary information-system infrastructure for concluding medical-service agreements electronically.

The court considered issues including:

Electronic identification.

Electronic acceptance of contractual terms.

Electronic signatures.

Patient-account functionality.

Technical integration with medical information systems.

The court identified problems with the lower courts' treatment of the technical requirements and set aside the relevant decisions for further consideration.

Legal principle: The legal recognition of electronic medical-service contracts does not eliminate the need for reliable identification, electronic consent and appropriate technical infrastructure.

This is relevant to telemedicine platforms that provide biotechnology consultations through paid online services.

ГАРАНТ

 

Case 3. Kirovsky District Court of Irkutsk, April 2020

Case No. 2A-1206/2020

This case concerned an internet website advertising the possibility of obtaining medical certificates remotely without actual medical attendance or the examinations required by law.

The prosecutor sought to prohibit the dissemination of the information.

The court considered the applicable rules governing the issuance of medical certificates and the requirement for actual medical examination where legally necessary.

Judicial outcome: The court declared the relevant website information prohibited from distribution in Russia.

Legal principle: Digital delivery cannot be used to circumvent statutory medical examination and certification requirements.

The case is relevant to biotechnology telemedicine because remote diagnostic systems must not be used to manufacture medical conclusions or certificates without the required clinical foundation.

Sudact

 

Case 4. Balashikha City Court, 2018

Case No. 2-168/2018

This case concerned an attempt to challenge the legality of telemedicine-related activities.

The court considered the legal framework governing telemedicine and referred to Article 36.2 of Federal Law No. 323-FZ.

The court rejected the claim, recognising that the statutory framework permitted medical assistance using telemedicine technologies.

Legal principle: Telemedicine is a legally recognised form of medical interaction, rather than an inherently unlawful substitute for conventional medical services.

This decision is historically relevant because it illustrates the development of Russian judicial recognition of telemedicine after the introduction of Article 36.2.

nami-rf.ru

 

Case 5. Moscow Regional Court – Medical negligence during remote postoperative treatment

A further relevant medical-liability decision concerned postoperative treatment involving remote consultations.

The patient had undergone treatment for a congenital leg condition. During the postoperative outpatient period, the treating doctor provided remote consultations without the necessary in-person follow-up examinations.

The medical treatment involved an apparatus requiring regular adjustment and monthly in-person monitoring.

The appellate court considered the treatment as a continuous medical process rather than isolating the postoperative stage from the earlier treatment.

It found deficiencies in the organisation of treatment and awarded:

Refund of the medical-service payment of 195,000 roubles.

Moral-damage compensation of 200,000 roubles.

Legal principle: Remote consultations do not excuse a medical provider from carrying out necessary physical examinations and follow-up monitoring.

This is an important principle for telemedicine involving biotechnology devices, implants and continuous biological monitoring.

Факультет Медицинского Права

 

12. Civil, administrative and criminal liability

Telemedicine providers and biotechnology companies may face several forms of legal liability.

A. Civil liability

Under the Russian Civil Code and consumer-protection legislation, a medical organisation may be liable for:

Negligent remote diagnosis.

Incorrect treatment recommendations.

Failure to arrange necessary physical examinations.

Defective medical devices.

Unlawful disclosure of medical information.

Harm caused by defective diagnostic software.

Breach of medical-service contracts.

Relevant provisions include Articles 15, 151, 1064, 1095 and 1096 of the Russian Civil Code.

B. Administrative liability

Administrative penalties may arise under the Code of Administrative Offences of the Russian Federation.

Relevant provisions include:

ProvisionSubject
Article 6.3Violations of sanitary and epidemiological requirements
Article 6.30Failure to inform citizens about the availability of medical assistance in specified circumstances
Article 13.11Violations of personal-data legislation
Article 14.1Conducting entrepreneurial activities in violation of licensing requirements
Article 14.4Sale of goods or provision of services of inadequate quality

The applicable provision depends on the conduct and the legal elements established in the particular case.

C. Criminal liability

Serious violations may also create criminal liability.

Relevant provisions of the Russian Criminal Code include:

Article 109 – causing death by negligence.

Article 118 – causing serious harm to health by negligence.

Article 137 – violation of personal privacy.

Article 238 – provision of services that do not meet safety requirements, where its statutory elements are satisfied.

Article 293 – negligence by public officials in applicable circumstances.

For example, if a biotechnology telemedicine system produces an incorrect diagnostic recommendation and a medical professional negligently relies on it, liability will depend on causation, professional duties, fault and the applicable statutory requirements.

13. Experimental legal regimes and biotechnology innovation

Russia has established an experimental legal regime framework under Federal Law No. 258-FZ of 31 July 2020, On Experimental Legal Regimes in the Sphere of Digital Innovations.

This legislation is significant for innovative telemedicine services.

Article 36.2 of Federal Law No. 323-FZ expressly recognises certain possibilities for modifying or excluding ordinary telemedicine requirements for private healthcare organisations participating in an approved experimental legal regime.

Such exceptions are not automatic.

They must be authorised under the relevant programme, and financial support for medical assistance provided under the relevant experimental regime cannot be drawn from public budgets or compulsory medical insurance.

This framework can facilitate experimentation with:

AI-assisted healthcare.

Remote diagnosis.

Digital biotechnology platforms.

Innovative medical monitoring systems.

Advanced medical information technologies.

Consultant Plus+1

14. Major legal challenges

Legal challengeMain concern
Genomic privacyUnauthorised disclosure of genetic information
AI diagnosisIncorrect automated medical recommendations
Remote examinationInability to physically examine a patient
Medical-device safetyDefective biosensors and diagnostic systems
Cross-border dataUnlawful transfer of patient information
Medical negligenceIncorrect remote treatment
Electronic consentInvalid or inadequately documented consent
Biotechnology researchSecondary use of biological information
LicensingUnauthorised medical activity
Digital evidenceAuthenticity of electronic medical records

15. Suggestions for improving Russian biotechnology telemedicine law

Several reforms could improve the legal framework.

1. Special genomic-data protection: Establish clearer rules for collecting, storing and sharing genomic information in telemedicine.

2. AI accountability: Clarify the respective responsibilities of software developers, medical organisations and treating professionals.

3. Cross-border cooperation: Develop clearer rules for international medical consultations and cross-border diagnostic services.

4. Patient consent: Improve electronic consent procedures for genetic testing and biotechnology-based treatment.

5. Medical-device regulation: Strengthen monitoring of AI-powered diagnostic devices and remote biosensors.

6. Cybersecurity: Introduce stronger technical safeguards for electronic medical records and biological information.

7. Medical negligence standards: Develop clearer standards for deciding when remote treatment must be replaced by an in-person examination.

16. Conclusion

Biotechnology Telemedicine Law in Russia represents the intersection of healthcare regulation, biotechnology, digital innovation, medical-device safety, genetic privacy and professional medical responsibility.

The most important legal foundation is Article 36.2 of Federal Law No. 323-FZ, supplemented by Ministry of Health Order No. 193n of 2025.

The judicial decisions discussed above demonstrate several important principles:

Doctor-to-doctor telemedicine consultations can be legally permissible.

Electronic medical-service agreements require appropriate technical and legal safeguards.

Online medical services cannot circumvent compulsory medical examination requirements.

Remote consultations do not remove the obligation to provide appropriate physical follow-up.

Medical organisations remain accountable for the quality and safety of their services.

The central legal principle is that technological innovation cannot replace the legal duties of medical professionals to protect patient health, confidentiality and safety.

17. Important legal references and research sources

Legal authorityRelevance
Constitution of Russia, Articles 21, 23, 24, 41 and 46Fundamental rights
Federal Law No. 323-FZ (2011)Healthcare and telemedicine
Federal Law No. 152-FZ (2006)Personal-data protection
Federal Law No. 99-FZ (2011)Medical licensing
Federal Law No. 61-FZ (2010)Medicines
Federal Law No. 258-FZ (2020)Experimental digital regimes
Federal Law No. 149-FZ (2006)Information technology
Ministry of Health Order No. 193n (2025)Telemedicine procedures
Russian Civil CodeCivil liability
Russian Criminal CodeCriminal liability
Russian Administrative Offences CodeAdministrative penalties

Primary research sources:

Russian Ministry of Health – Federal Law No. 323-FZ.

Ministry of Health Order No. 193n of 2025.

Ninth Court of Cassation – Case No. 8G-12682/2024.

Irkutsk District Court – Case No. 2A-1206/2020.

Medical negligence and remote postoperative treatment decision.

Research qualification: The judicial decisions above are illustrative applications of telemedicine, medical-service and patient-protection law. They should not all be treated as biotechnology-specific precedents. The precise scope of a decision should be checked against its full judgment and procedural history before citing it in litigation or academic publication. The statutory discussion reflects the framework identified in the cited materials, including the 2025 telemedicine order.

I can also prepare the next topic, Biotechnology Telemedicine Liability Law in Russia – Detailed Explanation With Case Laws, in the same academic legal-research format.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT